Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Cell Rep ; 16(2): 419-431, 2016 07 12.
Article in English | MEDLINE | ID: mdl-27346348

ABSTRACT

PI3K activity determines positive and negative selection of B cells, a key process for immune tolerance and B cell maturation. Activation of PI3K is balanced by phosphatase and tensin homolog (Pten), the PI3K's main antagonistic phosphatase. Yet, the extent of feedback regulation between PI3K activity and Pten expression during B cell development is unclear. Here, we show that PI3K control of this process is achieved post-transcriptionally by an axis composed of a transcription factor (c-Myc), a microRNA (miR17-92), and Pten. Enhancing activation of this axis through overexpression of miR17-92 reconstitutes the impaired PI3K activity for positive selection in CD19-deficient B cells and restores most of the B cell developmental impairments that are evident in CD19-deficient mice. Using a genetic approach of deletion and complementation, we show that the c-Myc/miR17-92/Pten axis critically controls PI3K activity and the sensitivity of immature B cells to negative selection imposed by activation-induced cell death.


Subject(s)
Antigens, CD19/genetics , B-Lymphocytes/physiology , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction , Animals , Antigens, CD19/metabolism , Cell Death , Cells, Cultured , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/metabolism , Genetic Complementation Test , Heterozygote , Mice, Inbred C57BL , Mice, Transgenic , MicroRNAs/metabolism , PTEN Phosphohydrolase/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Ribonuclease III/genetics , Ribonuclease III/metabolism
2.
J Biol Chem ; 289(21): 14996-5004, 2014 May 23.
Article in English | MEDLINE | ID: mdl-24719332

ABSTRACT

NF-κB is an important transcription factor in the immune system, and aberrant NF-κB activity contributes to malignant diseases and autoimmunity. In T cells, NF-κB is activated upon TCR stimulation, and signal transduction to NF-κB activation is triggered by a cascade of phosphorylation events. However, fine-tuning and termination of TCR signaling are only partially understood. Phosphatases oppose the role of kinases by removing phosphate moieties. The catalytic activity of the protein phosphatase PP2A has been implicated in the regulation of NF-κB. PP2A acts in trimeric complexes in which the catalytic subunit is promiscuous and the regulatory subunit confers substrate specificity. To understand and eventually target NF-κB-specific PP2A functions it is essential to define the regulatory PP2A subunit involved. So far, the regulatory PP2A subunit that mediates NF-κB suppression in T cells remained undefined. By performing a siRNA screen in Jurkat T cells harboring a NF-κB-responsive luciferase reporter, we identified the PP2A regulatory subunit B56γ as negative regulator of NF-κB in TCR signaling. B56γ was strongly up-regulated upon primary human T cell activation, and B56γ silencing induced increased IκB kinase (IKK) and IκBα phosphorylation upon TCR stimulation. B56γ silencing enhanced NF-κB activity, resulting in increased NF-κB target gene expression including the T cell cytokine IL-2. In addition, T cell proliferation was increased upon B56γ silencing. These data help to understand the physiology of PP2A function in T cells and the pathophysiology of diseases involving PP2A and NF-κB.


Subject(s)
NF-kappa B/immunology , Protein Phosphatase 2/immunology , Receptors, Antigen, T-Cell/immunology , Signal Transduction/immunology , Blotting, Western , Cells, Cultured , Gene Expression/genetics , Gene Expression/immunology , Humans , I-kappa B Kinase/immunology , I-kappa B Kinase/metabolism , I-kappa B Proteins/immunology , I-kappa B Proteins/metabolism , Interleukin-2/genetics , Interleukin-2/immunology , Interleukin-2/metabolism , Isoenzymes/immunology , Isoenzymes/metabolism , Jurkat Cells , Lymphocyte Activation/immunology , NF-KappaB Inhibitor alpha , NF-kappa B/metabolism , Phosphorylation/immunology , Protein Kinase C/immunology , Protein Kinase C/metabolism , Protein Kinase C-theta , Protein Phosphatase 2/genetics , Protein Phosphatase 2/metabolism , RNA Interference , Receptors, Antigen, T-Cell/metabolism , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
3.
Immunity ; 37(4): 697-708, 2012 Oct 19.
Article in English | MEDLINE | ID: mdl-23084358

ABSTRACT

Signal transduction to nuclear factor-kappa B (NF-κB) involves multiple kinases and phosphorylated target proteins, but little is known about signal termination by dephosphorylation. By RNAi screening, we have identified protein phosphatase 4 regulatory subunit 1 (PP4R1) as a negative regulator of NF-κB activity in T lymphocytes. PP4R1 formed part of a distinct PP4 holoenzyme and bridged the inhibitor of NF-κB kinase (IKK) complex and the phosphatase PP4c, thereby directing PP4c activity to dephosphorylate and inactivate the IKK complex. PP4R1 expression was triggered upon activation and proliferation of primary human T lymphocytes and deficiency for PP4R1 caused sustained and increased IKK activity, T cell hyperactivation, and aberrant NF-κB signaling in NF-κB-addicted T cell lymphomas. Collectively, our results unravel PP4R1 as a previously unknown activation-associated negative regulator of IKK activity in lymphocytes whose downregulation promotes oncogenic NF-κB signaling in a subgroup of T cell lymphomas.


Subject(s)
Phosphoprotein Phosphatases/immunology , Signal Transduction , T-Lymphocytes/immunology , Biocatalysis , Cell Differentiation , Cells, Cultured , Holoenzymes/immunology , Humans , I-kappa B Kinase/immunology , I-kappa B Kinase/metabolism , Lymphocyte Activation , NF-kappa B/immunology , NF-kappa B/metabolism , Phosphoprotein Phosphatases/genetics , RNA Interference
4.
Proc Natl Acad Sci U S A ; 106(34): 14508-13, 2009 Aug 25.
Article in English | MEDLINE | ID: mdl-19706536

ABSTRACT

Activation of the NF-kappaB pathway in T cells is required for induction of an adaptive immune response. Hematopoietic progenitor kinase (HPK1) is an important proximal mediator of T-cell receptor (TCR)-induced NF-kappaB activation. Knock-down of HPK1 abrogates TCR-induced IKKbeta and NF-kappaB activation, whereas active HPK1 leads to increased IKKbeta activity in T cells. Yet, the precise molecular mechanism of this process remains elusive. Here, we show that HPK1-mediated NF-kappaB activation is dependent on the adaptor protein CARMA1. HPK1 interacts with CARMA1 in a TCR stimulation-dependent manner and phosphorylates the linker region of CARMA1. Interestingly, the putative HPK1 phosphorylation sites in CARMA1 are different from known PKC consensus sites. Mutations of residues S549, S551, and S552 in CARMA1 abrogated phosphorylation of a CARMA1-linker construct by HPK1 in vitro. In addition, CARMA1 S551A or S5549A/S551A point mutants failed to restore HPK1-mediated and TCR-mediated NF-kappaB activation and IL-2 expression in CARMA1-deficient T cells. Thus, we identify HPK1 as a kinase specific for CARMA1 and suggest HPK1-mediated phosphorylation of CARMA1 as an additional regulatory mechanism tuning the NF-kappaB response upon TCR stimulation.


Subject(s)
CARD Signaling Adaptor Proteins/metabolism , Guanylate Cyclase/metabolism , NF-kappa B/metabolism , Protein Serine-Threonine Kinases/metabolism , T-Lymphocytes/metabolism , Animals , Binding Sites , CARD Signaling Adaptor Proteins/genetics , COS Cells , Cell Line , Cells, Cultured , Chlorocebus aethiops , Electrophoresis, Polyacrylamide Gel , Guanylate Cyclase/genetics , Humans , Immunoprecipitation , Jurkat Cells , Mutation , NF-kappa B/genetics , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/genetics , RNA, Small Interfering/genetics , Receptors, Antigen, T-Cell/metabolism , T-Lymphocytes/cytology , Transfection
5.
Crit Rev Oncol Hematol ; 66(1): 52-64, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18289867

ABSTRACT

Lymphocytes of the adaptive immune system play a crucial role in defending the organism against pathogens. Initial stimulation via antigen receptors induces activation and proliferation of lymphocytes to generate effector cells that clear the pathogen from the body. During the shut-down of the immune response activated lymphocytes are removed by two mechanisms. T cells that are restimulated during the end of the immune response die by activation-induced cell death (AICD), whereas activated lymphocytes which are not restimulated die by activated cell autonomous death (ACAD). Here, we discuss the regulation of AICD and ACAD in T cells and review the role of cytokines, T cell receptor (TCR) proximal signaling mediators like hematopoietic progenitor kinase 1 (HPK1) and the NF-kappaB pathway. We distinguish between AICD dependent on or independent of death receptor ligation, and discuss caspase-independent death of T cells.


Subject(s)
Apoptosis , Lymphocyte Activation , T-Lymphocytes/physiology , Animals , Cell Survival , Cytokines/physiology , Humans , NF-kappa B/physiology , Protein Serine-Threonine Kinases/physiology , Receptors, Antigen, T-Cell/physiology , T-Lymphocytes/immunology , fas Receptor/physiology
6.
Blood ; 110(12): 3968-77, 2007 Dec 01.
Article in English | MEDLINE | ID: mdl-17712048

ABSTRACT

Life and death of peripheral lymphocytes is strictly controlled to maintain physiologic levels of T and B cells. Activation-induced cell death (AICD) is one mechanism to delete superfluous lymphocytes by restimulation of their immunoreceptors and it depends partially on the CD95/CD95L system. Recently, we have shown that hematopoietic progenitor kinase 1 (HPK1) determines T-cell fate. While full-length HPK1 is essential for NF-kappaB activation in T cells, the C-terminal fragment of HPK1, HPK1-C, suppresses NF-kappaB and sensitizes toward AICD by a yet undefined cell death pathway. Here we show that upon IL-2-driven expansion of primary T cells, HPK1 is converted to HPK1-C by a caspase-3 activity below the threshold of apoptosis induction. HPK1-C selectively blocks induction of NF-kappaB-dependent antiapoptotic Bcl-2 family members but not of the proapoptotic Bcl-2 family member Bim. Interestingly, T and B lymphocytes from HPK1-C transgenic mice undergo AICD independently of the CD95/CD95L system but involving caspase-9. Knock down of HPK1/HPK1-C or Bim by small interfering RNA shows that CD95L-dependent and HPK1/HPK1-C-dependent cell death pathways complement each other in AICD of primary T cells. Our results define HPK1-C as a suppressor of antiapoptotic Bcl-2 proteins and provide a molecular basis for our understanding of CD95L-independent AICD of lymphocytes.


Subject(s)
Apoptosis/physiology , B-Lymphocytes/enzymology , Caspase 3/metabolism , Caspase 9/metabolism , Fas Ligand Protein/metabolism , Protein Serine-Threonine Kinases/metabolism , T-Lymphocytes/enzymology , Animals , Apoptosis Regulatory Proteins/metabolism , Bcl-2-Like Protein 11 , Humans , Interleukin-2/metabolism , Lymphocyte Activation/physiology , Membrane Proteins/metabolism , Mice , Mice, Transgenic , NF-kappa B/metabolism , Protein Serine-Threonine Kinases/genetics , Protein Structure, Tertiary/genetics , Proto-Oncogene Proteins/metabolism , T-Lymphocytes/cytology , fas Receptor/metabolism
7.
Nat Rev Immunol ; 7(7): 532-42, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17589543

ABSTRACT

During the course of an immune response, antigen-reactive T cells clonally expand and then are removed by apoptosis to maintain immune homeostasis. Life and death of T cells is determined by multiple factors, such as T-cell receptor triggering, co-stimulation or cytokine signalling, and by molecules, such as caspase-8 (FLICE)-like inhibitory protein (FLIP) and haematopoietic progenitor kinase 1 (HPK1), which regulate the nuclear factor-kappaB (NF-kappaB) pathway. Here, we discuss the concepts of activation-induced cell death (AICD) and activated cell-autonomous death (ACAD) in the regulation of life and death in T cells.


Subject(s)
Apoptosis/immunology , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Animals , Cell Proliferation , Cell Survival , Down-Regulation , Humans , Signal Transduction/immunology
8.
Psychother Psychosom Med Psychol ; 57(3-4): 161-9, 2007.
Article in German | MEDLINE | ID: mdl-17427099

ABSTRACT

BACKGROUND: The beneficial effects of Dialectical Behavior Therapy (DBT) for patients with borderline personality disorder (BPD) are well established. However, it is not well known whether this type of treatment relieves symptoms and signs of BPD in the long-term course thereafter and whether the results of DBT are transferable for patients with high comorbidity. METHODS: We conducted a follow-up examination of 50 consecutive inpatients with BPD as defined by DSM-IV. The patients were examined at admission, at discharge and 15 and 30 months after discharge. For the clinical diagnosis and to survey psychopathology we used the Structured Clinical Interview for DSM-IV (SCID), the Global Assessment of Functioning (GAF) and several self-rating-instruments. RESULTS: Compared to admission 30 months after discharge we observed the following results: A significant number of patients did not meet the DSM-IV criteria for BPD anymore, comorbidity (particularly mood disorders, drug or alcohol abuse/dependence and eating disorders) was reduced, psychosocial functioning was improved and general and BPD-typical symptoms were relieved. CONCLUSION: Our findings support the efficacy of DBT in an inpatient setting and show that the achieved success of therapy is stable for a prolonged period of time. Patients with high comorbidity seem to profit from DBT as well.


Subject(s)
Behavior Therapy , Borderline Personality Disorder/psychology , Borderline Personality Disorder/therapy , Adult , Borderline Personality Disorder/epidemiology , Comorbidity , Female , Follow-Up Studies , Humans , Inpatients , Long-Term Care , Male , Psychiatric Status Rating Scales , Self Concept , Social Behavior
9.
IEEE Trans Biomed Eng ; 54(2): 253-61, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17278582

ABSTRACT

Knowledge of the loads to which orthopedic implants are subjected is a fundamental prerequisite for their optimal biomechanical design, long-term success, and improved rehabilitation outcomes. In vivo load measurements are more accurate than those obtained using mathematical musculoskeletal models. An inductively powered integrated circuit inside the implant measures six load components as well as the temperature and supplied voltage. This low-power circuit includes a 9-channel multiplexer, a programmable memory, a pulse interval modulator, and a radio-frequency transmitter. Together with a few passive components, the integrated circuit is mounted on a ceramic substrate with thick-film hybrid technology. The sensor signals are multiplexed, modulated, and transmitted to an external device. The microcontroller of the external device regulates the alternating magnetic field produced by a power oscillator and synchronizes the pulse interval modulated data stream. A personal computer displays forces, moments, and temperatures in real time. The new telemetry transmitter has, thus far, been used for in vivo load measurements in three patients with shoulder endoprostheses. Eight instrumented vertebral body replacements are ready for implantation, and an instrumented tibial tray is being submitted to laboratory tests.


Subject(s)
Equipment Failure Analysis/instrumentation , Manometry/instrumentation , Monitoring, Physiologic/instrumentation , Prostheses and Implants , Telemetry/instrumentation , Transducers , Weight-Bearing , Equipment Design , Equipment Failure Analysis/methods
10.
Eur J Immunol ; 36(7): 1654-8, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16791883

ABSTRACT

While insufficient cell death of activated T cells can result in autoimmune disorders, elimination of too many T cells can lead to immunodeficiency. Therefore, T lymphocyte fate is highly regulated and requires that cells can switch from an apoptosis-resistant towards an apoptosis-sensitive state. This switch is tightly controlled by various effector molecules. Basically, two separate pathways control the fate of antigen-activated T cells: activation-induced cell death (AICD) and activated T cell autonomous death (ACAD). Autoreactive T lymphocytes are eliminated by restimulation via their T cell receptor (TCR) and undergo AICD involving death receptors (extrinsic pathway). In contrast, ACAD can lead to T cell deletion without TCR restimulation, and is determined by the ratio between anti- and pro-apoptotic Bcl-2 family members at the mitochondria (intrinsic pathway). While the extrinsic and the intrinsic pathway lead to caspase activation, non-caspase proteases (e.g., cathepsins) can be released by the lysosomes and might contribute to AICD as well as to ACAD. Activated T cells poses cell death escape mechanisms which are needed for survival of (memory) T cells, but are deleterious for autoimmune disorders or progression of T cell lymphomas.


Subject(s)
Apoptosis/immunology , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Animals , Cell Survival/immunology , Humans
11.
EMBO J ; 24(24): 4279-90, 2005 Dec 21.
Article in English | MEDLINE | ID: mdl-16341093

ABSTRACT

Restimulation of the T-cell receptor (TCR) in activated T cells induces CD95 (Fas/Apo-1)-mediated activation-induced cell death (AICD). The TCR-proximal mechanisms leading to AICD are elusive. Here we characterize hematopoietic progenitor kinase 1 (HPK1) as a differentially regulated TCR-proximal signaling protein involved in AICD of primary T cells. We show that HPK1 is a functional component of the endogenous IkappaB kinase (IKK) complex and is crucial for TCR-mediated NFkappaB activation. While full-length HPK1 enhances IKKbeta phosphorylation, siRNA-mediated knockdown of HPK1 blunts TCR-mediated NFkappaB activation and increases cell death. We also demonstrate proteolytic processing of HPK1 into HPK1-C, specifically in AICD-sensitive primary T cells. The cleavage product HPK1-C sequesters the inactive IKK complex and suppresses NFkappaB upon TCR restimulation by binding to IKKalpha and IKKbeta. T cells of HPK1-C transgenic mice are sensitized towards TCR-mediated AICD. Consequently, preventing HPK1-C generation in primary T cells by siRNA-mediated knockdown results in decreased AICD. Thus, these results show a novel mechanism of sensitization of T lymphocytes towards AICD by suppression of NFkappaB, and propose that HPK1 is a life/death switch in T lymphocytes.


Subject(s)
NF-kappa B/metabolism , Protein Serine-Threonine Kinases/metabolism , fas Receptor/metabolism , Animals , Apoptosis , COS Cells , Cell Death , Cell Line , Chlorocebus aethiops , Concanavalin A/pharmacology , Genes, Reporter , Humans , I-kappa B Kinase/metabolism , Immunoprecipitation , Jurkat Cells , Mice , Mice, Transgenic , Phenotype , Phosphorylation , Plasmids/metabolism , Protein Binding , Protein Structure, Tertiary , RNA, Small Interfering/metabolism , Receptors, Antigen, T-Cell/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , T-Lymphocytes/metabolism , Time Factors , Transfection
12.
Mol Cell Biol ; 25(6): 2364-83, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15743830

ABSTRACT

Adaptive immune signaling can be coupled to stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) and NF-kappaB activation by the hematopoietic progenitor kinase 1 (HPK1), a mammalian hematopoiesis-specific Ste20 kinase. To gain insight into the regulation of leukocyte signal transduction, we investigated the molecular details of HPK1 activation. Here we demonstrate the capacity of the Src family kinase Lck and the SLP-76 family adaptor protein Clnk (cytokine-dependent hematopoietic cell linker) to induce HPK1 tyrosine phosphorylation and relocation to the plasma membrane, which in lymphocytes results in recruitment of HPK1 to the contact site of antigen-presenting cell (APC)-T-cell conjugates. Relocation and clustering of HPK1 cause its enzymatic activation, which is accompanied by phosphorylation of regulatory sites in the HPK1 kinase activation loop. We show that full activation of HPK1 is dependent on autophosphorylation of threonine 165 and phosphorylation of serine 171, which is a target site for protein kinase D (PKD) in vitro. Upon T-cell receptor stimulation, PKD robustly augments HPK1 kinase activity in Jurkat T cells and enhances HPK1-driven SAPK/JNK and NF-kappaB activation; conversely, antisense down-regulation of PKD results in reduced HPK1 activity. Thus, activation of major lymphocyte signaling pathways via HPK1 involves (i) relocation, (ii) autophosphorylation, and (iii) transphosphorylation of HPK1 by PKD.


Subject(s)
Protein Kinase C/metabolism , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/immunology , T-Lymphocytes/enzymology , Adaptor Proteins, Signal Transducing/physiology , Amino Acid Sequence , Amino Acids/metabolism , Animals , Antigen-Presenting Cells/immunology , Cell Line , Cell Membrane/chemistry , Cell Membrane/metabolism , Humans , Lymphocyte Activation/immunology , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/physiology , Mitogen-Activated Protein Kinase 8/metabolism , Molecular Sequence Data , Mutation/genetics , NF-kappa B/metabolism , Peptide Mapping , Phosphorylation , Protein Kinase C/genetics , Protein Serine-Threonine Kinases/analysis , Protein Serine-Threonine Kinases/genetics , Protein Structure, Tertiary/genetics , Protein Structure, Tertiary/physiology , Protein Transport/physiology , RNA, Antisense/genetics , Receptors, Antigen, T-Cell/agonists , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/immunology
13.
EMBO Rep ; 6(2): 165-70, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15678159

ABSTRACT

Eukaryotic transcriptional regulation often involves regulatory elements separated from the cognate genes by long distances, whereas appropriately positioned insulator or enhancer-blocking elements shield promoters from illegitimate enhancer action. Four proteins have been identified in Drosophila mediating enhancer blocking-Su(Hw), Zw5, BEAF32 and GAGA factor. In vertebrates, the single protein CTCF, with 11 highly conserved zinc fingers, confers enhancer blocking in all known chromatin insulators. Here, we characterize an orthologous CTCF factor in Drosophila with a similar domain structure, binding site specificity and transcriptional repression activity as in vertebrates. In addition, we demonstrate that one of the insulators (Fab-8) in the Drosophila Abdominal-B locus mediates enhancer blocking by dCTCF. Therefore, the enhancer-blocking protein CTCF and, most probably, the mechanism of enhancer blocking mediated by this remarkably versatile factor are conserved from Drosophila to humans.


Subject(s)
DNA-Binding Proteins/genetics , Drosophila Proteins/genetics , Drosophila/genetics , Enhancer Elements, Genetic , Homeodomain Proteins/genetics , Insulator Elements , Repressor Proteins/genetics , Amino Acid Sequence , Animals , CCCTC-Binding Factor , DNA-Binding Proteins/metabolism , Drosophila/metabolism , Drosophila Proteins/metabolism , Gene Expression Regulation/physiology , Homeodomain Proteins/metabolism , Humans , Molecular Sequence Data , Repressor Proteins/metabolism
14.
IEEE Trans Biomed Eng ; 49(12 Pt 2): 1600-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12549742

ABSTRACT

A novel bipolar transistor for extracellular recording the electrical activity of biological cells is presented, and the electrical behavior compared with the field-effect transistor (FET). Electrical coupling is examined between single cells separated from the heart of adults rats (cardiac myocytes) and both types of transistors. To initiate a local extracellular voltage, the cells are periodically stimulated by a patch pipette in voltage clamp and current clamp mode. The local extracellular voltage is measured by the planar integrated electronic sensors: the bipolar and the FET. The small signal transistor currents correspond to the local extracellular voltage. The two types of sensor transistors used here were developed and manufactured in the laboratory of our institute. The manufacturing process and the interfaces between myocytes and transistors are described. The recordings are interpreted by way of simulation based on the point-contact model and the single cardiac myocyte model.


Subject(s)
Action Potentials/physiology , Amplifiers, Electronic , Membrane Potentials/physiology , Microelectrodes , Models, Cardiovascular , Myocytes, Cardiac/physiology , Transistors, Electronic , Animals , Cells, Cultured , Coated Materials, Biocompatible , Computer Simulation , Electromagnetic Fields , Equipment Design , Equipment Failure Analysis/methods , Extracellular Space/physiology , Materials Testing/methods , Models, Neurological , Patch-Clamp Techniques/methods , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...